In a plot twist that benefits exactly no one, malaria - an ancient disease that the U.S. has been politely trying to show the door since 2005 - is making a comeback. The U.S. President’s Malaria Initiative, launched in 2005, has been one of the most effective government-run overseas programs, cutting death rates from malaria in supported countries by nearly half. Working alongside partners like the Global Fund to Fight AIDS, Tuberculosis and Malaria, it has prevented more than 2 billion cases of malaria and saved 14 million lives, most of them children. That’s a clear demonstration of American leadership and a nice boost to the U.S.’s reputation as a reliable partner in global health security.
But here’s the kicker: progress is slowing because the disease is evolving. Mosquitoes are adapting to our decades-old tools, and drugs and insecticides that once worked are losing their edge. Malaria is now the leading killer of children in many African countries. The authors argue that a renewed emphasis on fighting malaria should be central to the Trump administration’s America First Global Health Strategy - because when infectious diseases roar back, they don’t just stay “over there.” They threaten U.S. economic and national security.
The strategy promises a disciplined approach to global health aid, prioritizing areas where the U.S. holds a distinct advantage, particularly through American innovation. Malaria is well-suited to this vision. Breakthrough technologies developed and manufactured in the U.S. could sharply reduce transmission if deployed at scale. New spatial repellents from SC Johnson can protect families without constant compliance. Rapid diagnostics enable earlier treatment, and advanced vector-control methods and new medicines aim to outpace resistance. Malaria vaccines introduced through global immunization partnerships can reduce severe disease and child mortality when combined with bed nets and preventive treatments.
None of this is a silver bullet, but together they offer a real shot at wiping out malaria. And it’s not just about doing the right thing - it’s about doing the smart thing. Healthier countries are more stable, better trading partners, and less likely to produce instability that leads to conflict or migrants showing up at the U.S. border. For the U.S. military, the stakes are even clearer: in tropical environments, malaria historically has sidelined more American troops than combat itself. That’s why the Walter Reed Army Institute of Research has spent decades investing in prevention and treatment. Fighting malaria isn’t charity; it’s protecting our men and women in uniform.
There’s a reason malaria programs have had bipartisan support: they work, and they’re directly in America’s interests. One practical step is restoring clear accountability by transferring the powers of the U.S. Global Malaria Coordinator to a leader at the State Department, giving a senior official real authority over budget and strategy. If we lose sight of the goal now, malaria will come back stronger, costing more money down the line and giving ground to adversaries like China. We’re closer than ever to ending malaria for good - that didn’t happen by accident. It happened because the U.S. stayed engaged and demanded results. Finishing the job requires discipline, backing what works, and investing in American innovation. If we do that, this is a fight we will win.